Exercise and Soft Tissue Sarcoma (NCT04921917) | Clinical Trial Compass
RecruitingNot Applicable
Exercise and Soft Tissue Sarcoma
United States24 participantsStarted 2021-04-30
Plain-language summary
The purpose of this study is to evaluate the effect of a neoadjuvant (i.e. pre-treatment) exercise regimen on extremity function and postoperative wound healing. The study group will include patients with a primary diagnosis of soft tissue sarcoma undergoing treatment with neoadjuvant radiation therapy and surgical resection. Patients with upper or lower extremity sarcomas will be considered for enrollment.
Who can participate
Age range18 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Males and females within the ages of 18-85
✓. Diagnosis of soft tissue sarcoma that has been histologically confirmed by an approved reference pathologist
✓. Sarcoma of the upper or lower extremity location
✓. Treatment plan that includes neo-adjuvant radiation therapy followed by surgical resection
✓. Expected primary wound closure performed at the time at surgery
✓. Any disease stage
✓. Any tumor grade
✓. Any histologic subtype
Exclusion criteria
✕. Patients under the age of 18, or over the age of 85
✕. Treatment plan that does not include neo-adjuvant radiation and surgical excision
✕. Sarcoma location other than the upper or lower extremity
✕. History of radiation therapy to the tumor and/or surgical area prior to the current treatment being studied
✕. High dose steroid therapy (defined as \>5mg prednisone, or equivalent, with the last 30 days)
✕. Active treatment with chemotherapy within the last 30 days
What they're measuring
1
Number of patients with a wound complication after surgery as measured by wound complication form